{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:41:38Z","timestamp":1777081298094,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.110003","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:51:13Z","timestamp":1699689073000},"page":"110003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-4121","authenticated-orcid":false,"given":"Sara","family":"Ronchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1062-2930","authenticated-orcid":false,"given":"Alessandro","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Ingargiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Camarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Imparato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8480-0387","authenticated-orcid":false,"given":"Ernesto","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohssen","family":"Ansarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Benazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4920-2239","authenticated-orcid":false,"given":"Barbara","family":"Vischioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110003_b0005","unstructured":"RARECAREnet. Information Network on Rare Cancers, Available online from: (accessed on 21 December 2022)."},{"key":"10.1016\/j.radonc.2023.110003_b0010","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.3390\/cancers12113131","article-title":"Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy","volume":"12","author":"Teterycz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.110003_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106123","article-title":"Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers","volume":"134","author":"Arosio","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.coms.2021.11.008","article-title":"Management of Head and Neck Mucosal Melanoma","volume":"34","author":"Nenclares","year":"2022","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.radonc.2023.110003_b0025","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2147\/OTT.S182580","article-title":"Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma","volume":"16","author":"Na'ara","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.radonc.2023.110003_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","article-title":"Mucosal melanoma of the head and neck","volume":"112","author":"Ascierto","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2023.110003_b0035","first-page":"1616","article-title":"Effects of heavy ions (12C6+) on malignant melanoma B16F10 cells. Transl","volume":"11","author":"Zhang","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2023.110003_b0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.14338\/IJPT-D-20-00076","article-title":"The Role of Particle Therapy in Adenoid Cystic Carcinoma and Mucosal Melanoma of the Head and Neck","volume":"8","author":"Ebner","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2023.110003_b0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CMR.0000000000000082","article-title":"Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features","volume":"24","author":"Gru","year":"2014","journal-title":"Melanoma Res"},{"key":"10.1016\/j.radonc.2023.110003_b0050","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cancers12103022","article-title":"Carbon Ion Radiobiology","volume":"12","author":"Tinganelli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.110003_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijrobp.2008.07.056","article-title":"Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy","volume":"74","author":"Yanagi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110003_b0060","unstructured":"Mizoe JE, Hasegawa A, Jingu K, et al; Organizing Committee for the Working Group for Head Neck Cancer. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol. 2012 Apr;103(1):32-7. 10.1016\/j.radonc.2011.12.013. Epub 2012 Feb 8. PMID: 22321201."},{"key":"10.1016\/j.radonc.2023.110003_b0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jrr\/rrw117","article-title":"Long-term outcomes after carbon-ion radiotherapy for oral mucosal malignant melanoma","volume":"58","author":"Naganawa","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2023.110003_b0070","doi-asserted-by":"crossref","unstructured":"Koto M, Demizu Y, Saitoh JI, et al. Japan Carbon-Ion Radiation Oncology Study Group. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1054-1060. 10.1016\/j.ijrobp.2016.12.028. Epub 2016 Dec 26. PMID: 28332989.","DOI":"10.1016\/j.ijrobp.2016.12.028"},{"key":"10.1016\/j.radonc.2023.110003_b0075","doi-asserted-by":"crossref","unstructured":"Ikawa H, Koto M, Hayashi K, et al. Feasibility of carbon-ion radiotherapy for oral non-squamous cell carcinomas. Head Neck. 2019 Jun;41(6):1795-1803. 10.1002\/hed.25618. Epub 2019 Jan 24. PMID: 30676669; PMCID: PMC6590439.","DOI":"10.1002\/hed.25618"},{"key":"10.1016\/j.radonc.2023.110003_b0080","doi-asserted-by":"crossref","unstructured":"Takayasu Y, Kubo N, Shino M, et al. Working Group on Head and Neck Tumors. Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study. Cancer Med. 2019 Dec;8(17):7227-7235. 10.1002\/cam4.2614. Epub 2019 Oct 16. PMID: 31621203; PMCID: PMC6885871.","DOI":"10.1002\/cam4.2614"},{"key":"10.1016\/j.radonc.2023.110003_b0085","doi-asserted-by":"crossref","unstructured":"Zhang W, Hu W, Hu J, et al. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world. Cancer Sci. 2020 Dec;111(12):4465-4479. 10.1111\/cas.14650. Epub 2020 Oct 16. PMID: 32936975; PMCID: PMC7734163.","DOI":"10.1111\/cas.14650"},{"key":"10.1016\/j.radonc.2023.110003_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ctrv.2010.08.004","article-title":"Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons","volume":"37","author":"Ramaekers","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.110003_b0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejmp.2015.03.001","article-title":"The National Centre for Oncological Hadrontherapy (CNAO): Status and perspectives","volume":"31","author":"Rossi","year":"2015","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2023.110003_b0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/rpd\/ncv145","article-title":"In vivo radiobiological assessment of the new clinical carbon ion beams at CNAO","volume":"166","author":"Facoetti","year":"2015","journal-title":"Radiat Prot Dosim"},{"key":"10.1016\/j.radonc.2023.110003_b0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2016.05.031","article-title":"Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems","volume":"120","author":"Molinelli","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0110","article-title":"Brainstem NTCP and Dose Constraints for Carbon Ion RT-Application and Translation From Japanese to European RBE-Weighted Dose","volume":"24","author":"Dale","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0115","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1118\/1.4928397","article-title":"Dosimetric commissioning and quality assurance of scanned ion beams at the Italian National Center for Oncological Hadrontherapy","volume":"42","author":"Mirandola","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.110003_b0120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00550-7","article-title":"Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer","volume":"46","author":"Dawson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110003_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1748-717X-9-162","article-title":"High-dose proton beam therapy for sinonasal mucosal malignant melanoma","volume":"23","author":"Fuji","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijrobp.2010.04.071","article-title":"Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study","volume":"81","author":"Zenda","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110003_b0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2015.10.025","article-title":"Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses","volume":"118","author":"Zenda","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s12885-015-1750-7","article-title":"Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis","volume":"21","author":"Li","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.110003_b0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcms.2015.02.011","article-title":"Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma","volume":"43","author":"Wushou","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.radonc.2023.110003_b0150","doi-asserted-by":"crossref","unstructured":"Abt NB, Miller LE, Mokhtari TE, et al. Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors. Am J Otolaryngol. 2021 Apr 19;42(6):103070. 10.1016\/j.amjoto.2021.103070. Epub ahead of print. PMID: 33930681.","DOI":"10.1016\/j.amjoto.2021.103070"},{"key":"10.1016\/j.radonc.2023.110003_b0155","doi-asserted-by":"crossref","unstructured":"Grant-Freemantle MC, Lane O'Neill B, Clover AJP. The effectiveness of radiotherapy in the treatment of head and neck mucosal melanoma: Systematic review and meta-analysis. Head Neck. 2020 Sep 14. 10.1002\/hed.26470. Epub ahead of print. PMID: 32926490.","DOI":"10.1002\/hed.26470"},{"key":"10.1016\/j.radonc.2023.110003_b0160","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S0022215118002189","article-title":"Surgery alone versus post-operative radiotherapy for sinonasal malignant melanoma: a meta-analysis","volume":"132","author":"Hu","year":"2018","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.radonc.2023.110003_b0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/coa.13033","article-title":"Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis","volume":"43","author":"Caspers","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.radonc.2023.110003_b0170","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/hed.24256","article-title":"Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinus","volume":"38","author":"Mohr","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2023.110003_b0175","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/cncr.29443","article-title":"Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival","volume":"121","author":"Jensen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.110003_b0180","unstructured":"Sahovaler A, Ziai H, Cardemil F, et al. Importance of Margins, Radiotherapy, and Systemic Therapy in Mucosal Melanoma of the Head and Neck. Laryngoscope. 2021 Apr 15. 10.1002\/lary.29555. Epub ahead of print. PMID: 33856051."},{"key":"10.1016\/j.radonc.2023.110003_b0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.canrad.2021.06.014","article-title":"Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidance","volume":"26","author":"Leleu","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2023.110003_b0190","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.110003_b0195","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D'Angelo","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110003_b0205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41416-018-0207-6","article-title":"Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006","volume":"119","author":"Hamid","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2023.110003_b0210","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/cncr.30259","article-title":"The efficacy of anti-PD-1 agents in acral and mucosal melanoma","volume":"122","author":"Shoushtari","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.110003_b0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejca.2021.08.034","article-title":"Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study","volume":"157","author":"Umeda","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.110003_b0220","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2020.09.041","article-title":"Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors","volume":"109","author":"Helm","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110003_b0225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.18632\/oncotarget.26551","article-title":"Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma","volume":"10","author":"Takahashi","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2023.110003_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020228","article-title":"The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules","volume":"10","author":"Keisari","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.radonc.2023.110003_b0235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1346-8138.15256","article-title":"Local and disease control for nasal melanoma treated with radiation and concomitant anti-programmed death 1 antibody","volume":"47","author":"Hanaoka","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.radonc.2023.110003_b0240","unstructured":"Cavalieri S, Ronchi S, Barcellini A, et al. Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma. Radiother Oncol. 2021 Sep 8;164:1-5. 10.1016\/j.radonc.2021.08.021. Epub ahead of print. PMID: 34506831.Rossi S. The National Centre for Oncological Hadrontherapy (CNAO): Status and perspectives. Phys Med. 2015 Jun;31(4):333-51. 10.1016\/j.ejmp.2015.03.001. Epub 2015 Mar 31. PMID: 25840619."},{"key":"10.1016\/j.radonc.2023.110003_b0245","unstructured":"Cavalieri S, Vitolo V, Barcellini A, et al. Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC). Future Oncol. 2023 Mar 28. 10.2217\/fon-2022-0503. Epub ahead of print. PMID: 36974574."},{"key":"10.1016\/j.radonc.2023.110003_b0250","doi-asserted-by":"crossref","unstructured":"Demizu Y, Fujii O, Terashima K, et al. Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy. Strahlenther Onkol. 2014 Feb;190(2):186-91. 10.1007\/s00066-013-0489-9. Epub 2013 Dec 22. PMID: 24362502.","DOI":"10.1007\/s00066-013-0489-9"},{"key":"10.1016\/j.radonc.2023.110003_b0255","doi-asserted-by":"crossref","first-page":"E372","DOI":"10.1016\/j.ijrobp.2017.06.1489","article-title":"Hypofractionated carbon-ion radiation therapy for mucosal malignant melanoma in head and neck","volume":"99","author":"Shirai","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:09:00Z","timestamp":1734253740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023093106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":51,"alternative-id":["S0167814023093106"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110003","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110003"}}